Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




New Saliva Test Detects Alcohol Exposure

By LabMedica International staff writers
Posted on 25 Aug 2010
An innovative analytical test is capable of detecting Ethyl Sulfate (EtS) and Ethyl Glucuronide (EtG), produced by the body after alcohol exposure, in a simple saliva sample. More...


The Saliva-Alcohol Alco-Screen test is intended for use as a rapid, highly sensitive method to detect the presence of alcohol in saliva to provide an approximation of relative blood alcohol concentration, allowing for greater detection sensitivity than breath testing methods. The simple, one-step, two-minute test requires no instrumentation, calibration, or special training to be used effectively. For applications where a qualitative determination of blood alcohol concentration is required for forensic purposes, liquid chromatography-mass spectrometry-mass spectrometry (LC/MS/MS) technology is used for confirmation of the oral fluid test result.

Since the relationship between the amount of saliva alcohol and blood alcohol is 1:1, while with breath it is 0.000048:1, saliva serves as a more sensitive testing medium than breath. Another advantage of saliva analysis is ease of collection, since the sample is produced with direct observation that is not gender dependent (such as a urine test), and the oral fluid collector can be easily labeled and secured in a strict chain of custody procedures. Oral fluid samples also provide a good indication of recent drug use, as most drugs are present in the saliva for 2-4 days after use. The Saliva-Alcohol Alco-Screen test is a product of Forensic Laboratories (Denver, CO, USA).

"Our mass spectrometry division was one of the first to offer the quantitation of both EtG and EtS in urine,” said James Ruth, Ph.D., Forensic Laboratories' laboratory director. "Now we are the first to offer EtS in oral fluid.”

Both EtG and EtS are minor but important metabolites of alcohol, because they are more slowly eliminated from the body than alcohol itself and can thus be used to better document and detect alcohol. Both EtG and EtS have similar time spectra; one standard drink, in an average person, can be detectable for about 24 hours (using the lowest cutoffs of 100 ng/ml for EtG and 25 ng/ml for EtS), whereas urine alcohol will disappear following one drink within about 4 to 6 hours; after binge drinking EtG and/or EtS can be detected in urine for several days or more. However, while EtG is degraded in urine when certain bacteria are present (which can cause a false negative test), EtS has not been shown to be degraded by bacteria.

Related Links:

Forensic Laboratories



Gold Member
Collection and Transport System
PurSafe Plus®
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Pipette
Accumax Smart Series
HBV DNA Test
GENERIC HBV VIRAL LOAD VER 2.0
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.